NR1I2 and hepatocellular carcinoma: These findings suggest that PXR-mediated LASP2 overexpression may represent a novel therapeutic strategy for HCC, thereby providing new insights into the development of diagnostic and therapeutic tools targeting nuclear receptors such as PXR.